Prices of drugs going off patent to be slashed to 50%

In case of Fixed dose combinations (FDC) where one component is going off patent the ceiling price will be revised by reducing the present ceiling price by 50%, it further said. According to the notification, "the retail price of the new drug shall be arrived at by reducing fifty percent," it said. The Centre and the pharma industry had been working on a pricing mechanism for drugs that are going off patent for a year now.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mr74Oop
via IFTTT